India Pharma Outlook Team | Monday, 07 September 2026
The Centre’s HPV vaccination drive comes under close watch as public interest litigation seeks Supreme Court intervention over informed consent, safety protocols, and accountability.
A petition filed by the Universal Health Organization challenges the government-backed human papillomavirus vaccination program, arguing that it violates the constitutional rights of parents and minor children.
The PIL demands immediate suspension of the school-based component until authorities put a legally compliant consent framework in place.
With the matter expected to reach the Supreme Court this week, the case brings into focus the balance between public health goals and individual rights in India’s major cervical cancer prevention effort.
A petition has reached the Supreme Court challenging the manner in which the government implements its free nationwide HPV vaccination program.
The Universal Health Organization filed the public interest litigation, alleging violations of constitutional guarantees of informed consent, bodily autonomy, transparency, and accountability under Articles 14 and 21 of the Constitution. The PIL seeks suspension of the school-based component of the drive until a lawful informed-consent protocol takes effect.
The petition states that constitutional rights and public health objectives complement rather than conflict with each other. It argues that India’s vaccination programs should operate in a manner that preserves both individual rights and public trust.
Also Read: Why Vaccine Innovation Must Go Beyond Traditional Platforms
India officially launched the free nationwide HPV vaccination program in February this year to combat cervical cancer, one of the leading causes of cancer deaths among women in the country.
The program targets 15-year-old girls. The petition alleges that the drive proceeds without a lawful informed-consent framework, without adequate disclosure of risks and available alternatives, without a transparent adverse-event reporting mechanism, and without any vaccine injury compensation scheme.
The petition refers to the Parliamentary Standing Committee’s 72nd Report of 2013, which examined alleged irregularities in an earlier HPV demonstration project conducted by PATH. It insists that similar concerns regarding informed consent must not arise in the current nationwide drive.
The PIL puts forward several specific requests before the Supreme Court:
Representatives of the Universal Health Organization emphasize that public trust in immunization programs grows stronger when transparency, informed choice, and accountability guide public health policy.
The Supreme Court is expected to hear the matter this week. The outcome will determine how authorities balance the urgent need to prevent cervical cancer with the fundamental requirement of informed parental and individual consent in school-based vaccination campaigns. The petition positions the case as a test of whether public health initiatives can advance while fully respecting constitutional protections.